Found: 129
Select item for more details and to access through your institution.
A Prospective Multimodal Education Intervention for Providers Does Not Increase Hepatic Encephalopathy Treatment Rates.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 6, p. 1996, doi. 10.1007/s10620-024-08445-2
- By:
- Publication type:
- Article
Update on Transjugular Intrahepatic Portosystemic Shunt Use in Liver Disease.
- Published in:
- Gastroenterology & Hepatology, 2024, v. 20, n. 6, p. 348
- By:
- Publication type:
- Article
Working Memory in Patients with Varying Degree of Hepatic Encephalopathy (HE): A Pilot EEG-fNIRS Study.
- Published in:
- Neurochemical Research, 2024, v. 49, n. 6, p. 1529, doi. 10.1007/s11064-023-04034-3
- By:
- Publication type:
- Article
Unmet needs in treatment of symptomatic uncomplicated diverticular disease and prevention of recurrent acute diverticulitis: a scoping review.
- Published in:
- Therapeutic Advances in Gastroenterology, 2024, p. 1, doi. 10.1177/17562848241255297
- By:
- Publication type:
- Article
Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy.
- Published in:
- Therapeutic Advances in Gastroenterology, 2024, p. 1, doi. 10.1177/17562848241254267
- By:
- Publication type:
- Article
Bismuth subsalicylate, probiotics, rifaximin and vaccines for the prevention of travelers' diarrhea: a systematic review and network meta-analysis.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1361501
- By:
- Publication type:
- Article
Efficacy of a 1 day Rifaximin and Metronidazole Regimen and Mechanical Bowel Preparation for Preventing Surgical Site Infection in Minimally Invasive Colorectal Cancer Surgery: A Prospective Observational Study.
- Published in:
- American Surgeon, 2024, v. 90, n. 4, p. 550, doi. 10.1177/00031348231200667
- By:
- Publication type:
- Article
Influence of Covid-19 disease on hemostasis dynamics during extracorporeal membrane oxygenation (ECMO)<sup>1</sup>.
- Published in:
- Clinical Hemorheology & Microcirculation, 2024, v. 87, n. 1, p. 1, doi. 10.3233/CH-229105
- By:
- Publication type:
- Article
Rifaximin treatment shapes a unique metagenome‐metabolism network in patients with decompensated cirrhosis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 4, p. 762, doi. 10.1111/jgh.16484
- By:
- Publication type:
- Article
Effect of Trimebutine and Rifaximin on Breath Hydrogen and Methane by Glucose Breath Test in Patients With Functional Bloating: A Randomized Double-blind Clinical Trial.
- Published in:
- Journal of Neurogastroenterology & Motility, 2024, v. 30, n. 2, p. 220, doi. 10.5056/jnm23029
- By:
- Publication type:
- Article
Italian guidelines for the management of irritable bowel syndrome in children and adolescents: Joint Consensus from the Italian Societies of: Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP), Pediatrics (SIP), Gastroenterology and Endoscopy (SIGE) and Neurogastroenterology and Motility (SINGEM)
- Published in:
- Italian Journal of Pediatrics, 2024, v. 50, n. 1, p. 1, doi. 10.1186/s13052-024-01607-y
- By:
- Publication type:
- Article
Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis.
- Published in:
- BMC Gastroenterology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12876-024-03184-0
- By:
- Publication type:
- Article
Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-54117-6
- By:
- Publication type:
- Article
Research roundup.
- Published in:
- Gastrointestinal Nursing, 2024, v. 22, n. Supp1, p. S4, doi. 10.12968/gasn.2024.22.Sup1.S4
- By:
- Publication type:
- Article
Improved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-023-04844-7
- By:
- Publication type:
- Article
Severe Ulcerative Colitis Complicated by Malakoplakia Resulting in Proctocolectomy.
- Published in:
- ACG Case Reports Journal, 2024, v. 11, n. 1, p. 1, doi. 10.14309/crj.0000000000001257
- By:
- Publication type:
- Article
Rifaximin Treatment of Collagenous Colitis: A Randomised, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Inflammatory Intestinal Diseases, 2024, v. 9, n. 1, p. 22, doi. 10.1159/000536124
- By:
- Publication type:
- Article
Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy—A Review of the Past Decade's Literature Focusing on Incidence, Risk Factors, and Prophylaxis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 14, doi. 10.3390/jcm13010014
- By:
- Publication type:
- Article
The Management of Hepatic Encephalopathy from Ward to Domiciliary Care: Current Evidence and Gray Areas.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 166, doi. 10.3390/jcm13010166
- By:
- Publication type:
- Article
Norfloxacin versus rifaximin for spontaneous bacterial peritonitis prophylaxis: A randomized controlled trial.
- Published in:
- Journal of Krishna Institute of Medical Sciences (JKIMSU), 2024, v. 13, n. 1, p. 112
- By:
- Publication type:
- Article
Advances in Therapy for Irritable Bowel Syndrome with Diarrhea: Role of Rifaximin in Combination with Metronidazole.
- Published in:
- Journal of Medical Sciences (1011-4564), 2024, v. 44, n. 1, p. 1, doi. 10.4103/jmedsci.jmedsci_163_23
- By:
- Publication type:
- Article
Ameliorative Effect of L-carnitine VS L-carnitine with Rifaximin on Skeletal Muscle Changes in Experimentally Induced Liver Cirrhosis in Adult Male Albino Rats (Biochemical and Histological Study).
- Published in:
- Zagazig University Medical Journal, 2024, v. 30, n. 1, p. 279, doi. 10.21608/ZUMJ.2023.242977.2964
- By:
- Publication type:
- Article
NiFe<sub>2</sub>O<sub>4</sub>/GO Nanocomposite as an Effective Adsorbent for Modelling Removal of Rifaximin from Pharmaceutical Wastewater Using Box–Behnken Response Surface Methodology.
- Published in:
- Russian Journal of General Chemistry, 2023, v. 93, p. S934, doi. 10.1134/S1070363223170103
- By:
- Publication type:
- Article
Modeling and Optimization of Hybrid Fenton and Ultrasound Process for Crystal Violet Degradation Using AI Techniques.
- Published in:
- Water (20734441), 2023, v. 15, n. 24, p. 4274, doi. 10.3390/w15244274
- By:
- Publication type:
- Article
Adherence to rifaximin initiation and prescribing within King's College Hospital and transfer of prescribing to primary care.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
The Importance of Making an Accurate Diagnosis for Hepatic Encephalopathy.
- Published in:
- Gastroenterology & Hepatology, 2023, v. 9, n. 12, p. 740
- By:
- Publication type:
- Article
STUDY TO DETERMINE THE EFFICACY OF RIFAXIMIN AS A PROPHYLACTIC ANTIBIOTIC FOR ILEOSTOMY CLOSURE AND TO COMPARE WOUND INFECTION RATES WITH THOSE OF OTHER CONVENTIONAL ANTIBIOTICS.
- Published in:
- Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2023, v. 14, n. 6, p. 717
- By:
- Publication type:
- Article
Go with your gut: targeting the microbiome for treatment of irritable bowel syndrome.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 11, p. 373, doi. 10.1007/s40267-023-01027-8
- By:
- Publication type:
- Article
Assessment of the Water Sorption Capacity of Rifaximin Using the Dynamic Vapor Sorption Technique for Optimization of the Choice of Excipients and the Manufacturing Environment of Rifaximin Tablets.
- Published in:
- Journal of AOAC International, 2023, v. 106, n. 6, p. 1464, doi. 10.1093/jaoacint/qsad103
- By:
- Publication type:
- Article
Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 21, p. 6871, doi. 10.3390/jcm12216871
- By:
- Publication type:
- Article
Rifaximin Ameliorates Loperamide-Induced Constipation in Rats through the Regulation of Gut Microbiota and Serum Metabolites.
- Published in:
- Nutrients, 2023, v. 15, n. 21, p. 4502, doi. 10.3390/nu15214502
- By:
- Publication type:
- Article
Position of an expert panel on diagnosis of treatment of irritable bowel syndrome.
- Published in:
- Family Medicine & Primary Care Review, 2023, v. 25, n. 4, p. 472, doi. 10.5114/fmpcr.2023.132973
- By:
- Publication type:
- Article
Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 19, p. 14727, doi. 10.3390/ijms241914727
- By:
- Publication type:
- Article
Irritable bowel syndrome in adolescents.
- Published in:
- Journal of Alternative Medicine Research, 2023, v. 15, n. 4, p. 407
- By:
- Publication type:
- Article
Distinct Effects of Non-absorbed Agents Rifaximin and Berberine on the Microbiota-Gut-Brain Axis in Dysbiosis-induced Visceral Hypersensitivity in Rats.
- Published in:
- Journal of Neurogastroenterology & Motility, 2023, v. 29, n. 4, p. 520, doi. 10.5056/jnm22182
- By:
- Publication type:
- Article
Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier.
- Published in:
- Therapeutics & Clinical Risk Management, 2023, v. 19, p. 839, doi. 10.2147/TCRM.S425292
- By:
- Publication type:
- Article
Comparative UV Spectroscopic Method Analysis and Validation for Estimation of Rifaximin in Pharmaceutical Preparation.
- Published in:
- Journal of Drug Delivery & Therapeutics, 2023, v. 13, n. 9, p. 33, doi. 10.22270/jddt.v13i9.6193
- By:
- Publication type:
- Article
Rifaximin may induce rifampicin resistance in coagulase‐negative staphylococci.
- Published in:
- Liver International, 2023, v. 43, n. 9, p. 2039, doi. 10.1111/liv.15667
- By:
- Publication type:
- Article
Clinical Outcomes of Oral Zinc Therapy in Hepatic Encephalopathy Treatment.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 8, p. 899, doi. 10.1177/10600280221134283
- By:
- Publication type:
- Article
Post Marketing Observational Study of Fixed Dose Combination of Rifaximin and Metronidazole in The Management of Acute Diarrhea.
- Published in:
- Indonesian Journal of Gastroenterology, Hepatology & Digestive Endoscopy, 2023, v. 24, n. 2, p. 122, doi. 10.24871/2422023122-126
- By:
- Publication type:
- Article
Rifaximin Use, Adherence and Persistence in Patients with Hepatic Encephalopathy: A Real-World Study in the South of Italy.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4515, doi. 10.3390/jcm12134515
- By:
- Publication type:
- Article
利福昔明联合枯草杆菌二联活菌治疗 小肠细菌过度生长的研究.
- Published in:
- Journal of Practical Medicine / Shiyong Yixue Zazhi, 2023, v. 39, n. 14, p. 1815, doi. 10.3969/j.issn.1006-5725.2023.14.015
- By:
- Publication type:
- Article
Effect of subinhibitory doses of rifaximin on in vitro Pseudomonas aeruginosa adherence and biofilm formation to biotic and abiotic surface models.
- Published in:
- Polimery w Medycynie, 2023, v. 54, n. 2, p. 97, doi. 10.17219/pim/166584
- By:
- Publication type:
- Article
Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 12, p. 2090, doi. 10.1093/cid/ciad083
- By:
- Publication type:
- Article
Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 6, p. e2317188, doi. 10.1001/jamanetworkopen.2023.17188
- By:
- Publication type:
- Article
ANTIBIOTIC REFRACTORY POUCHITIS - CURRENT GUIDELINE TREATMENTS AND A NEED FOR CHANGE.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2023, v. 32, p. 82
- By:
- Publication type:
- Article
Antibiotics and Probiotics for Irritable Bowel Syndrome.
- Published in:
- Drugs, 2023, v. 83, n. 8, p. 687, doi. 10.1007/s40265-023-01871-y
- By:
- Publication type:
- Article
Ziziphus spina-christi Leaf-Derived Carbon Dots as a Fluorescence Nanosensor to Evaluate Rifaximin Antibacterial via Inner Filter Effect: Greenness and Whiteness Studies.
- Published in:
- Chemosensors, 2023, v. 11, n. 5, p. 275, doi. 10.3390/chemosensors11050275
- By:
- Publication type:
- Article
Gut Microbiota: a Perspective for Postpartum Depression.
- Published in:
- Gastrointestinal Nursing, 2023, v. 21, n. 4, p. 30, doi. 10.12968/gasn.2023.21.4.30
- By:
- Publication type:
- Article
Role of rifaximin in the management of alcohol‐associated hepatitis: A systematic review and meta‐analysis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 5, p. 703, doi. 10.1111/jgh.16179
- By:
- Publication type:
- Article